3TC
4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE
| Created: | 2006-10-26 |
| Last modified: | 2020-06-05 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 26 |
| Chiral Atom Count | 2 |
| Bond Count | 27 |
| Aromatic Bond Count | 6 |
Chemical Component Summary | |
|---|---|
| Name | 4-AMINO-1-[(2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]PYRIMIDIN-2(1H)-ONE |
| Synonyms | (-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; LAMIVUDINE; EPIVIR |
| Systematic Name (OpenEye OEToolkits) | 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one |
| Formula | C8 H11 N3 O3 S |
| Molecular Weight | 229.256 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 10.04 | O=C1N=C(N)C=CN1C2OC(SC2)CO |
| SMILES | CACTVS | 3.341 | NC1=NC(=O)N(C=C1)[CH]2CS[CH](CO)O2 |
| SMILES | OpenEye OEToolkits | 1.5.0 | C1C(OC(S1)CO)N2C=CC(=NC2=O)N |
| Canonical SMILES | CACTVS | 3.341 | NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2 |
| Canonical SMILES | OpenEye OEToolkits | 1.5.0 | C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N |
| InChI | InChI | 1.03 | InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1 |
| InChIKey | InChI | 1.03 | JTEGQNOMFQHVDC-NKWVEPMBSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB00709 |
|---|---|
| Name | Lamivudine |
| Groups |
|
| Description | A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV). |
| Synonyms |
|
| Brand Names |
|
| Indication | Lamivudine is indicated in combination with other antiretrovirals the treatment of HIV infection and chronic hepatitis B (HBV).[L51474] In combination with [dolutegravir], lamivudine is indicated for the treatment of HIV-1 in patients ≥12 years of age and weighing ≥25 kg.[L51469] |
| Categories |
|
| ATC-Code |
|
| CAS number | 134678-17-4 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Gag-Pol polyprotein | MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGL... | unknown | modulator |
| Reverse transcriptase/RNaseH | PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI... | unknown | inhibitor |
| DNA | - | unknown | binder |
| Protein P | MPLSYPHFRKLLLLDDEAGPLEEELPRLADEDLNRRVAADLNLQLPNVSI... | unknown | inhibitor |
| Deoxycytidine kinase | MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEV... | unknown | substrate |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 60825 |
| ChEMBL | CHEMBL141 |
| ChEBI | CHEBI:63577 |
| CCDC/CSD | QUWXOW, NUWKEX, RUKHAG01, WOMHEM, VISWAX, RUKHAG, COWTAK |
| COD | 7215923 |














